Designing oral drugs for better delivery through the gut
Rational Design of Oral Drugs Targeting Mucosa Delivery
This study is exploring new ways to deliver medications directly to the gut using tiny particles, making it easier and more comfortable for people with inflammatory diseases to take their medicine by mouth instead of getting injections.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Iowa State University NIH-funded |
| Lab location | 1 site (Ames, United States) |
| Project ID | NIH-10843780 on NIH RePORTER |
What this research studies
This research focuses on developing oral drug delivery systems that target the gut mucosa, which is a more patient-friendly alternative to injections. The project aims to understand how nanoparticles can be used to enhance the transport of drugs across the intestinal lining, addressing significant knowledge gaps in this area. By manipulating the surface properties of these nanoparticles, the researchers hope to create effective pathways for drug delivery that can improve treatment outcomes for patients with inflammatory diseases. The ultimate goal is to design oral medications that are safer, more efficient, and easier for patients to use.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients with inflammatory diseases who require effective oral medication.
Not a fit: Patients who do not have inflammatory conditions or those who cannot take oral medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and safer oral medications for patients, reducing the need for injections.
How similar studies have performed: Previous research has shown promise in using nanoparticles for drug delivery, indicating potential success for this approach.
Where this research is happening
Ames, United States
- Iowa State University — Ames, United States (Active)
Researchers
- Principal investigator: Wang, Qun — Iowa State University
- Study coordinator: Wang, Qun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.